.Back to listing
Thu, Oct 02
Ebola vaccine tests needlessly delayed, researchers claim
Stephan Becker is tired of waiting. The virologist at the University of Marburg in Germany is part of a consortium of scientists that is ready to do a safety trial of one of the candidate vaccines for Ebola. But the vaccine doses he’s supposed to test on 20 German volunteers are still in Canada. Negotiations with the U.S. company that holds the license for commercialization of the vaccine—which contains a gene for the Ebola surface protein stitched into a livestock pathogen known as vesicular stomatitis virus (VSV)—have needlessly delayed the start of the trial, Becker and several other scientists tell Science. “It’s making me mad, that we are sitting here and could be doing something, but things are not moving forward,” Becker says.